If any single word defines today’s global situation, it would be “volatility.”
Climate change is a tangible threat to the quality of life globally, and solutions will command our greatest efforts in innovation, social equity, and systems thinking. These are extraordinary times.
The response of the diagnostics and biomedical industry at the height of the SARS-CoV-2 pandemic showcased its power and agility in countering healthcare threats. A diverse community of researchers, manufacturers, and healthcare providers built a formidable front against an unknown virus. Action was immediate.
Over the long run, however, these industries also carry the responsibility to secure a safe and resilient planet for future generations. With operations that consume large amounts of water and energy, supply chains that span the globe, and product cycles that generate copious wastes, diagnostics and healthcare have a significant environmental impact. Among the issues underlying unsustainable manufacturing processes is the use of Substances of Very High Concern (SVHCs).